The average 12-month price target is approximately $32.73 to $32.93 , representing a forecasted upside of about 17% from the current price of $28.03 . Recent Adjustments:
JPMorgan Chase & Co. recently lowered its target slightly from $36.00 to (Overweight). czr stock buy or sell
Generally rated as a Buy or Moderate Buy , with roughly 62%–79% of covering analysts recommending a purchase. The average 12-month price target is approximately $32
Truist Financial raised its target to (Buy) on April 21, 2026. Generally rated as a Buy or Moderate Buy
As of April 28, 2026, carries an overall Buy consensus rating from Wall Street analysts, though recent reports suggest a more cautious Hold sentiment from some firms following earnings volatility. Analyst Ratings & Price Targets
Caesars is scheduled to report its Q1 2026 results today, , after the market closes.
Morgan Stanley holds an (Hold) rating with a $34.00 target. Key Financial Performance (Q1 2026)